Archean Chemical Industries Limited (ACI) Fair Value & Analysis
Basic Materials · IN · Market cap ₹64.3B
Fair value as of: Jun 29, 2026
From 16 valuation models · updated yesterday
Share price −0.3% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹488.22 – ₹713.81 · fair‑value band ₹110.36 – ₹169.62 · the ₹522.50 price screens above the ₹131.16 fair value. As of Jun 29, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Archean Chemical Industries Limited (ACI) currently trades at ₹522.50, while our model-based Fair Value estimate is ₹131.16 — implying the stock looks roughly 74.9% overvalued today. We read business quality at 97/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Archean Chemical Industries Limited generated revenue of ₹10.8B at a net margin of 9.9%. Revenue declined 12.9% year over year. It earns a return on equity of 5.6%. Net debt stands at ₹4.3B. Fundamentals as of Jun 29, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 29, 2026. TTM = trailing twelve months.
About the company
Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for use as a water-soluble fertiliser in agricultural applications. Archean Chemical Industries Limited was founded in 2003 and is based in Chennai, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Archean Chemical Industries Limited reported revenue of ₹10.8B in FY2026 versus ₹11.3B in FY2022, a compound −1.1%/yr. Reported net income was ₹1.1B in FY2026, compounding −13.2%/yr from FY2022.
Open the full interactive analysis →
Similar stocks
6 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jun 29, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | €448.00 | €191.66 | -57% |
| Shin-Etsu Chemical Co SHECY | $22.77 | $13.22 | -42% |
| BASF SE BAS | €50.82 | €9.45 | -81% |
| Ningxia Baofeng Energy Group 600989 | ¥21.72 | ¥42.42 | +95% |
| Dow Inc D1OW34 | R$43.91 | R$31.57 | -28% |
| Ganfeng Lithium Group 002460 | ¥65.65 | ¥18.75 | -71% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Archean Chemical Industries Limited (ACI) undervalued?
What is the fair value of ACI?
What is the quality score of ACI?
What is the revenue of Archean Chemical Industries Limited (ACI)?
What is the net profit margin of ACI?
Does Archean Chemical Industries Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.